These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25413558)

  • 21. Treatment of clozapine-associated weight gain: a systematic review.
    Whitney Z; Procyshyn RM; Fredrikson DH; Barr AM
    Eur J Clin Pharmacol; 2015 Apr; 71(4):389-401. PubMed ID: 25627831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine-induced DNA methylation in the hippocampus and cerebellum in genes mapped to human 22q11 and implicated in schizophrenia.
    Melka MG; Rajakumar N; O'Reilly R; Singh SM
    Psychiatr Genet; 2015 Apr; 25(2):88-94. PubMed ID: 25415458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting injectable antipsychotics: an underutilized treatment option.
    Heres S
    J Clin Psychiatry; 2014 Nov; 75(11):1263-5. PubMed ID: 25470087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.
    Ryu S; Yoo JH; Kim JH; Choi JS; Baek JH; Ha K; Kwon JS; Hong KS
    J Clin Psychopharmacol; 2015 Feb; 35(1):13-21. PubMed ID: 25485636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risperidone-induced mania: An emergent complication of treatment.
    Kavoor AR; Mitra S; Mondal SK; Das B
    J Pharmacol Pharmacother; 2014 Oct; 5(4):258-60. PubMed ID: 25422570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.
    Veale D; Miles S; Smallcombe N; Ghezai H; Goldacre B; Hodsoll J
    BMC Psychiatry; 2014 Nov; 14():317. PubMed ID: 25432131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aripiprazole long-acting for the maintenance treatment of schizophrenia.].
    Samalin L; Charpeaud T; Llorca PM
    Encephale; 2014 Dec; 40(6):487-494. PubMed ID: 25453734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist and antagonist effects of aripiprazole on D₂-like receptors controlling rat brain dopamine synthesis depend on the dopaminergic tone.
    Ma GF; Raivio N; Sabrià J; Ortiz J
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling.
    Brust TF; Hayes MP; Roman DL; Watts VJ
    Biochem Pharmacol; 2015 Jan; 93(1):85-91. PubMed ID: 25449598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: a systematic review and meta-analysis of randomized-controlled trials.
    Srisurapanont M; Suttajit S; Maneeton N; Maneeton B
    J Psychiatr Res; 2015 Mar; 62():38-47. PubMed ID: 25619176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review.
    Ennis ZN; Damkier P
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):315-20. PubMed ID: 25536446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aripiprazole adjunct treatment in bipolar I or II disorder, depressed state: a 2-year clinical study.
    Malempati RN
    J Nerv Ment Dis; 2015 Jan; 203(1):58-64. PubMed ID: 25536100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Chinese First-Episode Schizophrenia Trial: background and study design.
    Han X; Yuan YB; Yu X; Zhao JP; Wang CY; Lu Z; Yang FD; Dong H; Wu YF; Ungvari GS; Xiang YT; Chiu HF
    East Asian Arch Psychiatry; 2014 Dec; 24(4):169-73. PubMed ID: 25482837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to discontinuation of antipsychotic drugs in a schizophrenia cohort: influence of current treatment strategies.
    Kroken RA; Kjelby E; Wentzel-Larsen T; Mellesdal LS; Jørgensen HA; Johnsen E
    Ther Adv Psychopharmacol; 2014 Dec; 4(6):228-39. PubMed ID: 25489474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daytime sleepiness and EEG abnormalities in patients treated with second generation antipsychotic agents.
    Okruszek L; Jernajczyk W; Wierzbicka A; Waliniowska E; Jakubczyk T; Jarema M; Wichniak A
    Pharmacol Rep; 2014 Dec; 66(6):1077-82. PubMed ID: 25443738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists.
    Fagiolini A; Brugnoli R; Di Sciascio G; De Filippis S; Maina G
    Expert Opin Pharmacother; 2015 Apr; 16(5):727-37. PubMed ID: 25672664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin.
    Lu ML; Wang TN; Lin TY; Shao WC; Chang SH; Chou JY; Ho YF; Liao YT; Chen VC
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():47-50. PubMed ID: 25496829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of aripiprazole for delirium in the elderly: a short review.
    Kirino E
    Psychogeriatrics; 2015 Mar; 15(1):75-84. PubMed ID: 25514894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do antipsychotics increase diabetes risk in children and adolescents?
    Galling B; Correll CU
    Expert Opin Drug Saf; 2015 Feb; 14(2):219-41. PubMed ID: 25480466
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.